BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37336235)

  • 1. Automatic ECG-based detection of left ventricular hypertrophy and its predictive value in haemodialysis patients.
    Letz T; Hörandtner C; Braunisch MC; Gundel P; Matschkal J; Bachler M; Lorenz G; Körner A; Schaller C; Lattermann M; Holzinger A; Heemann U; Wassertheurer S; Schmaderer C; Mayer CC
    Physiol Meas; 2023 Jul; 44(7):. PubMed ID: 37336235
    [No Abstract]   [Full Text] [Related]  

  • 2. Peguero-Lo Presti criteria for the diagnosis of left ventricular hypertrophy: A systematic review and meta-analysis.
    Yu Z; Song J; Cheng L; Li S; Lu Q; Zhang Y; Lin X; Liu D
    PLoS One; 2021; 16(1):e0246305. PubMed ID: 33513186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrocardiographic parameters of left ventricular hypertrophy and prediction of mortality in hemodialysis patients.
    Braunisch MC; Gundel P; Werfel S; Mayer CC; Bauer A; Haller B; Günthner R; Lorenz G; Angermann S; Matschkal J; Schaller C; Holzmann-Littig C; Kemmner S; Mann J; Krieter A; Renders L; Wassertheurer S; Schmidt G; Heemann U; Malik M; Schmaderer C
    J Nephrol; 2022 Jan; 35(1):233-244. PubMed ID: 34014512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term repeatability of the peguero-lo presti electrocardiographic left ventricular hypertrophy criteria.
    Drager D; Soliman EZ; Meyer ML; Zhang ZM; Alonso A; Heiss G; Whitsel EA
    Ann Noninvasive Electrocardiol; 2021 May; 26(3):e12829. PubMed ID: 33591619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of the novel Peguero Lo-Presti criterion for electrocardiographic detection of left ventricular hypertrophy in a black African population.
    Nyaga UF; Boombhi J; Menanga A; Mokube M; Ndomo Mevoula CS; Kingue S; Noubiap JJ
    J Clin Hypertens (Greenwich); 2021 Jun; 23(6):1186-1193. PubMed ID: 33783138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A meta-analytic evaluation of the diagnostic accuracy of the electrocardiographic Peguero-Lo Presti criterion for left ventricular hypertrophy.
    Noubiap JJ; Agbaedeng TA; Nyaga UF; Nkoke C; Jingi AM
    J Clin Hypertens (Greenwich); 2020 Jul; 22(7):1145-1153. PubMed ID: 32608577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peguero-Lo Presti criteria for diagnosis of left ventricular hypertrophy: a cardiac magnetic resonance validation study.
    Guerreiro C; Azevedo P; Ladeiras-Lopes R; Ferreira N; Barbosa AR; Faria R; Almeida J; Primo J; Melica B; Braga P
    J Cardiovasc Med (Hagerstown); 2020 Jun; 21(6):437-443. PubMed ID: 32251077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ECG left ventricular hypertrophy as a risk predictor of sudden cardiac death.
    Porthan K; Kenttä T; Niiranen TJ; Nieminen MS; Oikarinen L; Viitasalo M; Hernesniemi J; Jula AM; Salomaa V; Huikuri HV; Albert CM; Tikkanen JT
    Int J Cardiol; 2019 Feb; 276():125-129. PubMed ID: 30293667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ECG left ventricular hypertrophy in aortic stenosis: Relationship with cardiac structure, invasive hemodynamics, and long-term mortality.
    Sager P; Rusch A; Weber L; Breuss A; Appert S; Brenner R; Buser M; Ammann P; Rickli H; Maeder MT
    Clin Cardiol; 2024 Jan; 47(1):e24155. PubMed ID: 37740622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Novel Peguero-Lo Presti Electrocardiographic Left Ventricular Hypertrophy Criteria in a Large Asian Population: Newer May Not Be Better.
    Sun GZ; Wang HY; Ye N; Sun YX
    Can J Cardiol; 2018 Sep; 34(9):1153-1157. PubMed ID: 30170670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimized electrocardiographic criteria for the detection of left ventricular hypertrophy in obesity patients.
    Snelder SM; van de Poll SWE; de Groot-de Laat LE; Kardys I; Zijlstra F; van Dalen BM
    Clin Cardiol; 2020 May; 43(5):483-490. PubMed ID: 31990994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic Ability of Peguero-Lo Presti Electrocardiographic Left Ventricular Hypertrophy Criterion in Severe Aortic Stenosis.
    Gamrat A; Trojanowicz K; Surdacki MA; Budkiewicz A; Wąsińska A; Wieczorek-Surdacka E; Surdacki A; Chyrchel B
    J Clin Med; 2021 Jun; 10(13):. PubMed ID: 34203345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
    Okin PM
    J Electrocardiol; 2009; 42(6):584-8. PubMed ID: 19631946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of relative wall thickness on electrocardiographic voltage measures in left ventricular hypertrophy: a novel factor contributing to poor diagnostic accuracy.
    Ye N; Sun GZ; Zhou Y; Wu SJ; Sun YX
    Postgrad Med; 2020 Mar; 132(2):141-147. PubMed ID: 31900004
    [No Abstract]   [Full Text] [Related]  

  • 15. Peguero Electrocardiographic Left Ventricular Hypertrophy Criteria and Risk of Mortality.
    Afify HMA; Waits GS; Ghoneum AD; Cao X; Li Y; Soliman EZ
    Front Cardiovasc Med; 2018; 5():75. PubMed ID: 30013976
    [No Abstract]   [Full Text] [Related]  

  • 16. Peguero-Lo Presti criteria modified by body surface area for the electrocardiographic diagnosis of left ventricular hypertrophy in Thai patients.
    Luangphiphat W; Phaisitkriengkrai A; Methavigul R; Methavigul K
    Asian Biomed (Res Rev News); 2021 Apr; 15(2):101-107. PubMed ID: 37551402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.
    Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Nieminen MS; Snapinn S; Harris KE; Aurup P; Edelman JM; Wedel H; Lindholm LH; Dahlöf B;
    JAMA; 2004 Nov; 292(19):2343-9. PubMed ID: 15547161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between ECG criteria and Echo criteria for left ventricular hypertrophy in a general Chinese population.
    Lv T; Yuan Y; Yang J; Wang G; Kong L; Li H; Li X; Sun Y; Li X; Zhang Z; Cheng X; Wu L; Tan X; Han B; Li H; Zhang Z; Wang J; Wu Y; Wang Y; Guo J; Zhang P
    Ann Noninvasive Electrocardiol; 2021 Sep; 26(5):e12880. PubMed ID: 34310813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients : the losartan intervention for endpoint (LIFE) reduction in hypertension study.
    Okin PM; Jern S; Devereux RB; Kjeldsen SE; Dahlöf B;
    Hypertension; 2000 Jan; 35(1 Pt 1):13-8. PubMed ID: 10642268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review.
    Bang CN; Devereux RB; Okin PM
    J Electrocardiol; 2014; 47(5):630-5. PubMed ID: 25052475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.